These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. AAV Serotypes and Their Suitability for Retinal Gene Therapy. Ebner LJA; Grimm C Adv Exp Med Biol; 2023; 1415():131-134. PubMed ID: 37440025 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis. Rakoczy EP; Narfström K Int J Biochem Cell Biol; 2014 Nov; 56():153-7. PubMed ID: 25286304 [TBL] [Abstract][Full Text] [Related]
9. Gene and cell-based therapies for inherited retinal disorders: An update. Sengillo JD; Justus S; Tsai YT; Cabral T; Tsang SH Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):349-366. PubMed ID: 27862925 [TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Adeno-Associated Viral Gene Therapy in Patients With Retinal Degeneration: A Systematic Review and Meta-Analysis. Sobh M; Lagali PS; Ghiasi M; Montroy J; Dollin M; Hurley B; Leonard BC; Dimopoulos I; Lafreniere M; Fergusson DA; Lalu MM; Tsilfidis C Transl Vis Sci Technol; 2023 Nov; 12(11):24. PubMed ID: 37982768 [TBL] [Abstract][Full Text] [Related]
12. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates. Kotterman MA; Yin L; Strazzeri JM; Flannery JG; Merigan WH; Schaffer DV Gene Ther; 2015 Feb; 22(2):116-26. PubMed ID: 25503696 [TBL] [Abstract][Full Text] [Related]
13. Effective delivery of large genes to the retina by dual AAV vectors. Trapani I; Colella P; Sommella A; Iodice C; Cesi G; de Simone S; Marrocco E; Rossi S; Giunti M; Palfi A; Farrar GJ; Polishchuk R; Auricchio A EMBO Mol Med; 2014 Feb; 6(2):194-211. PubMed ID: 24150896 [TBL] [Abstract][Full Text] [Related]
14. Assessment of different virus-mediated approaches for retinal gene therapy of Usher 1B. Lopes VS; Diemer T; Williams DS Adv Exp Med Biol; 2014; 801():725-31. PubMed ID: 24664764 [TBL] [Abstract][Full Text] [Related]
15. Choroideremia: molecular mechanisms and development of AAV gene therapy. Patrício MI; Barnard AR; Xue K; MacLaren RE Expert Opin Biol Ther; 2018 Jul; 18(7):807-820. PubMed ID: 29932012 [TBL] [Abstract][Full Text] [Related]
16. [Gene Therapy for Inherited RETINAL AND OPTIC NERVE Disorders: Current Knowledge]. Ďuďáková Ľ; Kousal B; Kolářová H; Hlavatá L; Lišková P Cesk Slov Oftalmol; 2016; 72(4):128-136. PubMed ID: 27860478 [TBL] [Abstract][Full Text] [Related]
17. [Progress in research on pathogenic genes and gene therapy for inherited retinal diseases]. Zhu L; Cao C; Sun J; Gao T; Liang X; Nie Z; Ji Y; Jiang P; Guan M Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):118-123. PubMed ID: 28186610 [TBL] [Abstract][Full Text] [Related]
18. Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors. Colella P; Trapani I; Cesi G; Sommella A; Manfredi A; Puppo A; Iodice C; Rossi S; Simonelli F; Giunti M; Bacci ML; Auricchio A Gene Ther; 2014 Apr; 21(4):450-6. PubMed ID: 24572793 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Simonelli F; Maguire AM; Testa F; Pierce EA; Mingozzi F; Bennicelli JL; Rossi S; Marshall K; Banfi S; Surace EM; Sun J; Redmond TM; Zhu X; Shindler KS; Ying GS; Ziviello C; Acerra C; Wright JF; McDonnell JW; High KA; Bennett J; Auricchio A Mol Ther; 2010 Mar; 18(3):643-50. PubMed ID: 19953081 [TBL] [Abstract][Full Text] [Related]